top headlines
The Society for RNA Therapeutics (SRT) has expanded its leadership [...]
CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Glasgow medical technology company Nebu~Flow has secured a £2 million [...]
London-based technology company Apoha has emerged from stealth with $36 [...]
Crowdhelix has launched a new international innovation network focused on [...]
The World Bronchiectasis Conference (WBC) will return to Hannover, Germany, [...]
Poland-based AI drug development company Ingenix has raised €13 million [...]
Evogene has reported positive Phase 1 data for microbiome-based therapy [...]
